Literature DB >> 23698297

Systems to establish bunyavirus genome replication in the absence of transcription.

Carolin Klemm1, Juan Reguera, Stephen Cusack, Florian Zielecki, Georg Kochs, Friedemann Weber.   

Abstract

The L polymerase of bunyaviruses replicates and transcribes the viral genome. While replication products are faithful copies of the uncapped genomic RNA, transcription products contain capped 5' extensions which had been cleaved from host cell mRNAs. For La Crosse virus (LACV; genus Orthobunyavirus), the nuclease responsible for host cell mRNA cleavage is located at the N terminus of the L protein, with an active site of five conserved amino acids (H34, D52, D79, D92, and K94) surrounding two Mn(2+) ions (J. Reguera, F. Weber, and S. Cusack, PLoS Pathog. 6:e1001101, 2010). Here, we present reverse genetics systems and L mutants enabling us to study bunyaviral genome replication in the absence of transcription. Transcription was evaluated with an enhanced minigenome system consisting of the viral polymerase L, nucleocapsid protein N, a negative-sense minigenome, and--to alleviate antiviral host responses--a dominant-negative mutant (PKRΔE7) of the antiviral kinase protein kinase R (PKR). The transcriptional activity was strongly reduced by mutation of any of the five key amino acids, and the H34K, D79A, D92A, and K94A LACV L mutants were almost entirely silent in transcription. The replication activity of the L mutants was measured by packaging of progeny minigenomes into virus-like particles (VLPs). All mutant L proteins except K94A retained full replication activity. To test the broader applicability of our results, we introduced the homolog of mutation D79A (D111A) into the L sequence of Rift Valley fever virus (RVFV; genus Phlebovirus). As for LACV D79A, the RVFV D111A was incapable of transcription but fully active in replication. Thus, we generated mutants of LACV and RVFV L polymerases that are specifically deficient in transcription. Genome replication by bunyavirus polymerases can now be studied in the absence of transcription using convenient reverse genetics systems.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23698297      PMCID: PMC3700186          DOI: 10.1128/JVI.00371-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Mechanism of tripartite RNA genome packaging in Rift Valley fever virus.

Authors:  Kaori Terasaki; Shin Murakami; Kumari G Lokugamage; Shinji Makino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

3.  The Biology Workbench--a seamless database and analysis environment for the biologist.

Authors:  S Subramaniam
Journal:  Proteins       Date:  1998-07-01

4.  Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription.

Authors:  Juan Reguera; Friedemann Weber; Stephen Cusack
Journal:  PLoS Pathog       Date:  2010-09-16       Impact factor: 6.823

5.  Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses.

Authors:  Matthias Habjan; Nicola Penski; Valentina Wagner; Martin Spiegel; Anna K Overby; Georg Kochs; Juha T Huiskonen; Friedemann Weber
Journal:  Virology       Date:  2009-01-19       Impact factor: 3.616

6.  The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit.

Authors:  Alexandre Dias; Denis Bouvier; Thibaut Crépin; Andrew A McCarthy; Darren J Hart; Florence Baudin; Stephen Cusack; Rob W H Ruigrok
Journal:  Nature       Date:  2009-02-04       Impact factor: 49.962

7.  Amino acid changes within the Bunyamwera virus nucleocapsid protein differentially affect the mRNA transcription and RNA replication activities of assembled ribonucleoprotein templates.

Authors:  Cheryl T Walter; Diana F Costa Bento; Ana Guerrero Alonso; John N Barr
Journal:  J Gen Virol       Date:  2010-10-13       Impact factor: 3.891

8.  Bunyaviruses and the type I interferon system.

Authors:  Richard M Elliott; Friedemann Weber
Journal:  Viruses       Date:  2009-11-23       Impact factor: 5.048

9.  Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.

Authors:  Tetsuro Ikegami; Krishna Narayanan; Sungyong Won; Wataru Kamitani; C J Peters; Shinji Makino
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

10.  Genetic trans-complementation establishes a new model for influenza virus RNA transcription and replication.

Authors:  Núria Jorba; Rocío Coloma; Juan Ortín
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more
  17 in total

1.  A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus.

Authors:  Stephanie Devignot; Eric Bergeron; Stuart Nichol; Ali Mirazimi; Friedemann Weber
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

2.  Evidence for Viral mRNA Export from Ebola Virus Inclusion Bodies by the Nuclear RNA Export Factor NXF1.

Authors:  Lisa Wendt; Janine Brandt; Dmitry S Ushakov; Bianca S Bodmer; Matthew J Pickin; Allison Groseth; Thomas Hoenen
Journal:  J Virol       Date:  2022-08-30       Impact factor: 6.549

3.  Advancing the Rose Rosette Virus Minireplicon and Encapsidation System by Incorporating GFP, Mutations, and the CMV 2b Silencing Suppressor.

Authors:  Cesar D Urrutia; Gustavo Romay; Brian D Shaw; Jeanmarie Verchot
Journal:  Viruses       Date:  2022-04-17       Impact factor: 5.818

4.  Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein.

Authors:  Daniel Olal; Alexej Dick; Virgil L Woods; Tong Liu; Sheng Li; Stephanie Devignot; Friedemann Weber; Erica Ollmann Saphire; Oliver Daumke
Journal:  Nucleic Acids Res       Date:  2014-03-31       Impact factor: 16.971

5.  Comparative Structural and Functional Analysis of Bunyavirus and Arenavirus Cap-Snatching Endonucleases.

Authors:  Juan Reguera; Piotr Gerlach; Maria Rosenthal; Stephanie Gaudon; Francesca Coscia; Stephan Günther; Stephen Cusack
Journal:  PLoS Pathog       Date:  2016-06-15       Impact factor: 6.823

Review 6.  Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development.

Authors:  Fouad A Abolaban; Fathi M Djouider
Journal:  Open Life Sci       Date:  2021-06-02       Impact factor: 0.938

7.  Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection.

Authors:  Ashwini Benedict; Neha Bansal; Svetlana Senina; Idris Hooper; Lindsay Lundberg; Cynthia de la Fuente; Aarthi Narayanan; Bradford Gutting; Kylene Kehn-Hall
Journal:  Front Microbiol       Date:  2015-07-08       Impact factor: 5.640

8.  Conserved Endonuclease Function of Hantavirus L Polymerase.

Authors:  Sylvia Rothenberger; Giulia Torriani; Maria U Johansson; Stefan Kunz; Olivier Engler
Journal:  Viruses       Date:  2016-05-02       Impact factor: 5.048

Review 9.  Phleboviruses and the Type I Interferon Response.

Authors:  Jennifer Deborah Wuerth; Friedemann Weber
Journal:  Viruses       Date:  2016-06-22       Impact factor: 5.048

Review 10.  Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins.

Authors:  Hoai J Ly; Tetsuro Ikegami
Journal:  Virol J       Date:  2016-07-02       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.